Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ascendance Biotechnology

Ascendance Biotechnology
2015 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include application-directed, cellular micro-patterning drug and chemical screening, predictive analysis and basic research, enabling pharmaceutical companies to get basic stem cell research through clinical manufacturing using products that are translatable to the clinic.

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Acquirer
IVT Holdings
Primary Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ascendance Biotechnology’s full profile, request a free trial.

Ascendance Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Mar-2018 00000 Completed Generating Revenue
2. Angel (individual) 17-May-2016 00000 00000 Completed Startup
1. Angel (individual) 21-Dec-2015 $650K $650K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ascendance Biotechnology Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
00000000 Formerly VC-backed San Diego, CA 00 0000 0&0
00 000000 Corporate Backed or Acquired Bridgewater, NJ 000000&0
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 00000 0000000000 00000
000000 0000000000 Venture Capital-Backed Austin, TX 0 00.000 0000000000 0 00.000
To view this company’s complete list of competitors, request access »

Ascendance Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Nov-2015 000000 00 000000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Ascendance Biotechnology Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AgeX Therapeutics Corporation Minority 000 0000 000000 0

Ascendance Biotechnology Executive Team (2)

Name Title Board
Seat
Contact
Info
Vincent Zurawski Ph.D Co-Founder, Chief Executive Officer & Board Member
Jeffrey Janus Co-Founder, President & Board Member

Ascendance Biotechnology Board Members (6)

Name Representing Role Since Contact
Info
Jeffrey Janus Ascendance Biotechnology Co-Founder, President & Board Member 000 0000
Morton Collins Ph.D Self Board Member 000 0000
Robert Wilkins Ascendance Biotechnology Board Member 000 0000
Vincent Zurawski Ph.D Ascendance Biotechnology Co-Founder, Chief Executive Officer & Board Member 000 0000

2 Former Board Members

You’re viewing 4 of 6 board members. Get the full list »